The Toronto-based company
VisualSonics has launched a new medical imaging product that it says could revolutionize the world of cancer diagnosis. The Vevo LAZR is an acoustic photoimaging technology that allows researchers to study tumour growth in real time. VisualSonics claims that this process allows doctors access to real-time information of tumour growth and mutation that they have never had before.
VisualSonics President and CEO Anil Amlani says his company's new technology will allow "acceleration in the study of cancer and its treatment enabling early detection, early diagnosis and rapid personalized treatment." In a
statement provided by VisualSonics, David A. Jaffray of the
Ontario Cancer Institute at the Princess Margaret Hospital says, "This imaging system has the potential to transform the way we diagnose and treat cancer."
VisualSonics specializes in medical imaging technology that allows real-time,
in vivo, systems for research. Based in North York, it is a division of the Seattle-based company
SonoSite.
Writer: Edward Keenan
Source: Shailja Tewari, VisualSonics